| 1 |
B cells and tertiary lymphoid structures promote immunotherapy response
Beth Ann Helmink et al. · Nature
Open access |
15 Jan 2020 |
2,809 |
| 2 |
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al. · Nature
|
15 Jan 2020 |
2,468 |
| 3 |
Direct multiplexed measurement of gene expression with color-coded probe pairs
Gary K. Geiss et al. · Nature Biotechnology
|
17 Feb 2008 |
2,147 |
| 4 |
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pagès et al. · The Lancet
|
May 2018 |
2,133 |
| 5 |
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease
Yingyue Zhou et al. · Nature Medicine
Open access |
2020 |
1,249 |
| 6 |
Multiplex digital spatial profiling of proteins and RNA in fixed tissue
Christopher R. B. Merritt et al. · Nature Biotechnology
|
May 2020 |
1,134 |
| 7 |
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi et al. · Journal for ImmunoTherapy of Cancer
Open access |
Mar 2020 |
1,116 |
| 8 |
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher Garris et al. · Immunity
Open access |
Dec 2018 |
972 |
| 9 |
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Leonie Voorwerk et al. · Nature Medicine
Open access |
13 May 2019 |
916 |
| 10 |
Spatially organized multicellular immune hubs in human colorectal cancer
Karin Pelka et al. · Cell
Open access |
26 Aug 2021 |
910 |
| 11 |
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Toni Marie Delorey et al. · Nature
Open access109 authors |
29 Apr 2021 |
889 |
| 12 |
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
Christian U. Blank et al. · Nature Medicine
|
4 Oct 2018 |
869 |
| 13 |
Gene expression markers of Tumor Infiltrating Leukocytes
Patrick J. Danaher, Sarah E. Warren, Lucas M. Dennis et al. · Journal for ImmunoTherapy of Cancer
Open access |
15 Feb 2017 |
866 |
| 14 |
High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging
Shanshan He et al. · Nature Biotechnology
|
6 Oct 2022 |
844 |
| 15 |
Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study
Pieter Mestdagh et al. · Nature Methods
|
29 Jun 2014 |
657 |
| 16 |
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Brett Wallden, James Justin Storhoff, Torsten O. Nielsen et al. · BMC Medical Genomics
Open access |
21 Aug 2015 |
584 |
| 17 |
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan et al. · Nature Medicine
Open access |
21 Mar 2022 |
533 |
| 18 |
Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses
Ido Amit et al. · Science
Open access |
3 Sep 2009 |
504 |
| 19 |
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
Fernanda G. Herrera et al. · Cancer Discovery
Open access |
3 Sep 2021 |
453 |
| 20 |
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
William L. Hwang et al. · Nature Genetics
Open access |
28 Jul 2022 |
437 |
| 21 |
Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
Patrick J. Danaher, Sarah E. Warren, Rongze Olivia. Lu et al. · Journal for ImmunoTherapy of Cancer
Open access |
21 Jun 2018 |
434 |
| 22 |
The spatial landscape of lung pathology during COVID-19 progression
André F. Rendeiro, Hiranmayi Ravichandran, Yaron Bram et al. · Nature
Open access |
29 Mar 2021 |
409 |
| 23 |
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
Michael Gnant et al. · Annals of Oncology
Open access |
17 Dec 2013 |
408 |
| 24 |
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
Mona Khan et al. · Cell
Open access |
Nov 2021 |
400 |
| 25 |
Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer
Ivana Šestak, Richard Buus, Jack M. Cuzick et al. · JAMA Oncology
Open access |
15 Feb 2018 |
336 |
| 26 |
Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity
Stacia K. Wyman, Emily Christine Knouf, Rachael K. Parkin et al. · Genome Research
Open access |
3 Aug 2011 |
334 |
| 27 |
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Geoffrey L. Uy et al. · Blood
Open access |
15 Sep 2020 |
332 |
| 28 |
Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data
Patrick J. Danaher, Young‐Mi Kim, Brenn Nelson et al. · Nature Communications
Open access |
19 Jan 2022 |
326 |
| 29 |
Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease
Alba Garrido-Trigo et al. · Nature Communications
Open access |
26 Jul 2023 |
325 |
| 30 |
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
Torsten O. Nielsen, Brett Wallden, Carl Schaper et al. · BMC Cancer
Open access |
13 Mar 2014 |
319 |
| 31 |
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
Lauren Brady, Michelle Kriner, Ilsa M. Coleman et al. · Nature Communications
Open access |
3 Mar 2021 |
308 |
| 32 |
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
Kathrin Renner et al. · Cell Reports
Open access |
Oct 2019 |
308 |
| 33 |
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
Felice Rivellese et al. · Nature Medicine
Open access |
19 May 2022 |
302 |
| 34 |
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Sara M. Tolaney et al. · Journal of Clinical Oncology
Open access |
2 Apr 2019 |
283 |
| 35 |
The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer
William A. Freed-Pastor et al. · Cancer Cell
Open access |
5 Aug 2021 |
273 |
| 36 |
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection
Niyati Desai et al. · Nature Communications
Open access |
9 Dec 2020 |
273 |
| 37 |
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2
Susanne Krasemann et al. · Stem Cell Reports
Open access |
20 Jan 2022 |
248 |
| 38 |
Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer
Ivana Šestak, Mitch Dowsett, Lila A. Zabaglo et al. · JNCI Journal of the National Cancer Institute
Open access |
12 Sep 2013 |
223 |
| 39 |
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Jayakumar Narayanan Vadakekolathu et al. · Science Translational Medicine
Open access |
3 Jun 2020 |
218 |
| 40 |
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation
Giuseppe Valentino Masucci, Alessandra Cesano, Rachael Elizabeth Hawtin et al. · Journal for ImmunoTherapy of Cancer
Open access |
9 Nov 2016 |
202 |
| 41 |
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
Julia Kargl, Xiaodong Zhu, Huajia Zhang et al. · JCI Insight
Open access |
18 Dec 2019 |
199 |
| 42 |
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
David Andrew Sallman et al. · Blood
Open access |
30 Jul 2020 |
193 |
| 43 |
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
Daniel Butler et al. · Nature Communications
Open access |
12 Mar 2021 |
191 |
| 44 |
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis
Douglas Buckner Johnson et al. · Nature Medicine
Open access |
22 Jul 2019 |
178 |
| 45 |
High-Plex Predictive Marker Discovery for Melanoma Immunotherapy–Treated Patients Using Digital Spatial Profiling
Maria I Toki, Christopher R. B. Merritt, Pok Fai Wong et al. · Clinical Cancer Research
Open access |
12 Jun 2019 |
176 |
| 46 |
Future perspectives in melanoma research
Paolo A. Ascierto et al. · Journal of Translational Medicine
Open access |
15 Nov 2016 |
175 |
| 47 |
Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter™ Assay System
Vladislav A. Malkov, Kyle A. Serikawa, NOEL BALANTAC et al. · BMC Research Notes
Open access |
2009 |
174 |
| 48 |
GeoMx™ RNA Assay: High Multiplex, Digital, Spatial Analysis of RNA in FFPE Tissue
Daniel R. Zollinger, Stan E. Lingle, Kristina Sorg et al. · Methods in molecular biology
Book chapter |
2020 |
160 |
| 49 |
Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones
Елена Дмитриевна Денисенко et al. · Nature Communications
Open access |
3 Apr 2024 |
157 |
| 50 |
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML
Jayakumar Narayanan Vadakekolathu et al. · Blood Advances
Open access |
15 Oct 2020 |
156 |